Table 3 Clinical PathoScope performance on the 16S amplimer dataset
| Â | Â | Clinical PathoScope Results | |
|---|---|---|---|
Accession | Sample type | Species identified | Reads assigned (%) |
SRR949994 | S. aureus ATCC No. 25923 MSSA | S. aureus | 3,479 (98.0) |
| Â | Â | P. aeruginosa | 36 (1.0) |
SRR949995 | E. faecalis ATCC No. 51299 | E. faecalis | 2,351 (89.8) |
| Â | Â | S. aureus | 139 (5.3) |
| Â | Â | E. hirae | 44 (1.7) |
| Â | Â | P. aeruginosa | 42 (1.6) |
SRR949996 | P. aeruginosa ATCC No. 27853 | P. aeruginosa | 5,661(82.3) |
| Â | Â | E. coli | 1,021 (14.9) |
SRR949997 | E. coli ATCC No. 25922 | E. coli | 4,169 (94.7) |
| Â | Â | S. enterica | 66 (1.6) |
SRR949998 | Mixture of E. coli, E. faecalis, P. aeruginosa, S. aureus (above) | E. coli | 14,280 (31.9) |
| Â | E. faecalis | 14,306 (31.9) | |
| Â | Â | P. aeruginosa | 8,771 (19.6) |
| Â | Â | S. aureus | 6,594 (14.8) |
SRR950015 | Clinical Sample (F1) | A. baumannii | 4,889 (59.4) |
| Â | Â | P. aeruginosa | 3,177 (38.7) |
SRR950024 | Clinical Sample (G1) | P. aeruginosa | 1,131 (94.5) |
| Â | Â | E. coli | 45 (3.8) |
SRR950025 | Clinical Sample (H1) | E. aerogenes | 587 (85.9) |
| Â | Â | P. aeruginosa | 18 (2.6) |
| Â | Â | Erwinia sp. Ejp617 | 19 (2.8) |
| Â | Â | E. coli | 18 (2.6) |
| Â | Â | S. enterica | 9 (1.3) |
| Â | Â | E. asburiae | 10 (1.5) |
| Â | Â | S. intermedius | 8 (1.2) |